Free. Unsubscribe any time.
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC filed 16 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 24 transactions and 246,228 shares. None carries the SEC's AFF10B5ONE flag; all 16 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-03-20, came 9 days after the one before it (2026-03-11) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 13,976 shares, 7,752 more than the 6,224 in the filing before it.
- Its 16 plan statements rank 3rd of the 3 companies the register carries in Virginia, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 16 filings on file run from 2025-01-14 to 2026-03-20, and state 6 plan adoption dates, from 2024-08-14 to 2025-12-05.
Trades in COLLEGIUM PHARMACEUTICAL, INC 24
- Kuhlmann Shirley R. — 2025-01-10 · S · 21,400 shares
- Kuhlmann Shirley R. — 2025-01-10 · S · 6,100 shares
- Dreyer Scott — 2025-03-06 · S · 3,295 shares
- Dreyer Scott — 2025-03-06 · S · 15,387 shares
- Tupper Colleen — 2025-03-06 · S · 1,949 shares
- Dreyer Scott — 2025-03-07 · S · 2,348 shares
- Tupper Colleen — 2025-03-07 · S · 1,504 shares
- Dreyer Scott — 2025-03-11 · S · 15,387 shares
- Tupper Colleen — 2025-03-11 · S · 10,445 shares
- Tupper Colleen — 2025-03-14 · S · 977 shares
- Dreyer Scott — 2025-03-20 · S · 1,927 shares
- Tupper Colleen — 2025-03-20 · S · 1,206 shares
Adoption dates in COLLEGIUM PHARMACEUTICAL, INC 6
- 2024-08-14 — stated in 4 filings
- 2024-08-28 — stated in 6 filings
- 2024-09-13 — stated in 1 filing
- 2025-05-30 — stated in 1 filing
- 2025-09-03 — stated in 2 filings
- 2025-12-05 — stated in 2 filings
Results prints in COLLEGIUM PHARMACEUTICAL, INC 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
Trades before a print in COLLEGIUM PHARMACEUTICAL, INC 2
- 0 days before the 2025-11-06 print — 2025-11-06 · S · Tupper Colleen · 25,142 shares
- 0 days before the 2025-11-06 print — 2025-11-06 · S · Tupper Colleen · 4,858 shares
- 48 days before the 2025-02-27 print — 2025-01-10 · S · Kuhlmann Shirley R. · 21,400 shares
- 48 days before the 2025-02-27 print — 2025-01-10 · S · Kuhlmann Shirley R. · 6,100 shares
- 48 days before the 2025-05-08 print — 2025-03-21 · S · Dreyer Scott · 18,881 shares
- 48 days before the 2025-05-08 print — 2025-03-21 · S · Tupper Colleen · 6,396 shares
- 49 days before the 2025-05-08 print — 2025-03-20 · S · Dreyer Scott · 1,927 shares
- 49 days before the 2025-05-08 print — 2025-03-20 · S · Tupper Colleen · 1,206 shares
- 50 days before the 2026-05-07 print — 2026-03-18 · S · Dieter David · 13,976 shares
- 55 days before the 2025-05-08 print — 2025-03-14 · S · Tupper Colleen · 977 shares
- 58 days before the 2025-05-08 print — 2025-03-11 · S · Dreyer Scott · 15,387 shares
- 58 days before the 2025-05-08 print — 2025-03-11 · S · Tupper Colleen · 10,445 shares
Interval to COLLEGIUM PHARMACEUTICAL, INC’s next reported results date
How the interval and sources are counted →
- 2within 5 days
- 2within 10 days
- 0shortest, days
- 0no later print
- Tupper Colleen 2025-11-06 · S · 0 days before the 2025-11-06 print · EVP & Chief Financial Officer
- Tupper Colleen 2025-11-06 · S · 0 days before the 2025-11-06 print · EVP & Chief Financial Officer
Adoption dates COLLEGIUM PHARMACEUTICAL, INC states
- 2024-08-14 in 4 filings
- 2024-08-28 in 6 filings
- 2024-09-13 in 1 filing
- 2025-05-30 in 1 filing
- 2025-09-03 in 2 filings
- 2025-12-05 in 2 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on September 13, 2024”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.